Combined adenovirus-mediated PTEN (AdVPTEN) gene therapy with DNA-damaging anticancer drug cisplatin chemotherapy, appeared to dramatically reduce the progression of a murine model of lung cancer, due to induction of growth arrest and apoptosis in tumor cells. Here, PTEN is linked to lung carcinoma.